Cochrane, Maria Crespo Leiro, Anne Dipchand, Brian Feingold, Kathleen Grady, Edward
Horn, Maryl Johnson, Donna Mancini, Sean Pinney, Heather Ross, Kari Wujcik, Andreas …

The advent of therapies for successful treatment of hepatitis C virus has allowed the heart
and lung transplant community to re-explore the use of hepatitis C virus–positive donors for …

The proposed donor heart selection guidelines provide evidence-based and expert-
consensus recommendations for the selection of donor hearts following brain death. These …

BACKGROUND Increased utilization of hepatitis C virus (HCV)-positive donors has
increased transplantation rates. However, high levels of viremia have been documented in …

BACKGROUND National data demonstrate that increasing opportunities exist for organ
donation among hepatitis C virus (HCV)–infected individuals. METHODS We developed a …

BACKGROUND Hepatitis C virus (HCV) donors should be categorized as HCV-viremic
(antibody [Ab] negative or positive/Nucleic Acid testing [NAT] positive) or HCV Ab+ …

Background. While heart transplantation is a highly effective treatment in patients with
advanced heart failure, the number of people waiting for a transplant exceeds the number of …

Background Because of ongoing shortages of donors for heart transplantation, the use of
donor candidates whose availabilities are the result of drug overdoses (ODs) has become …

Introduction Patients with end‐stage heart failure eligible for orthotopic heart transplantation
(OHT) exceed the number of available donor organs. With highly effective hepatitis C virus …

Objective To examine trends in utilization of hearts from hepatitis C virus (HCV) viremic
donors for transplantation, a strategy to expand organ availability. Methods The United …